Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma.
Zhang L, Pan L, Xiang B, Zhu H, Wu Y, Chen M, Guan P, Zou X, Valencia CA, Dong B, Li J, Xie L, Ma H, Wang F, Dong T, Shuai X, Niu T, Liu T.
Zhang L, et al. Among authors: xiang b.
Oncotarget. 2016 May 24;7(21):30876-91. doi: 10.18632/oncotarget.9021.
Oncotarget. 2016.
PMID: 27129167
Free PMC article.